NEW YORK
Once again, mayhem and mass destruction is back at the box office. It’s almost like old times. “Godzilla vs. Kong,” one of the few tentpoles to dare release during COVID times, is poised this weekend to set a new high in ticket sales during the pandemic. It won’t be the kind of blockbuster business such a big-budget release would typically manage, but experts forecast a launch of at least $25 million.
Opening-day ticket sales on Wednesday for “Godzilla vs. Kong” totaled $9.6 million, Warner Bros. said Thursday — a single-day pandemic record and more than most 2020-2021 opening weekend hauls. Last weekend, the monster mash pulled in an impressive $123.1 million internationally. In China, where moviegoing is close to pre-pandemic levels, the movie made about $70 million, double the debut of 2014′s “Godzilla.”
Aamir Khan: I am not a box-office king
For the first time in a long time, there’s the faint hint of a hit at the box office. “It’s a good omen that the tastes of the consumer have not shifted so much that there’s no possibility of restarting the movie business,” says Joshua Grode, chief executive of Legendary Entertainment, which produced “Godzilla vs. Kong.” “This tells everybody: the moviegoing business is here, and, yes, it may be different post-pandemic. But there is a viable industry there.”
Huge challenges remain to the revival of moviegoing. With so many cinemas shuttered for nearly an entire year, many moviegoers are out of the habit. Some are unlikely to return to sitting indoors with strangers until they’re vaccinated or the pandemic has ebbed. And even those who have been convinced of the safety of moviegoing by theaters’ health protocols, they now have only more in-home options. “Godzilla vs. Kong” is streaming simultaneously on HBO Max in North America.
But few scream big screen as much as King Kong and Godzilla. To help kickstart moviegoing and bring back a little chest-thumping swagger to theaters, the industry is counting on two of the movies’ most iconic, long-running leviathans. Laying another metropolis to waste might help movie theaters build themselves back up.
“The issue is less convincing consumers to go to the movies than it is convincing studios to open their movies,” says Rich Gelfond, IMAX’S chief executive. “There’s been a hesitancy on the part of Hollywood studios to release movies because they haven’t been convinced the demand is there. What I really hope this weekend shows is that there is a lot of demand there and it convinces them to open a lot of movies that have been sitting on the shelf.”
Since the launch of “Tenet” fizzled last August, and virus cases soared, most studios have been postponing or rerouting their biggest releases to streaming services. But as vaccinations have ramped up and restrictions have eased, more theaters have opened. About 60% of theaters will be open this weekend, according to data firm Comscore. On Monday, Los Angeles County will expand cinema capacity from 25% to 50%. For the first time since last winter, wide release will mean playing in more than 3,000 theaters. That’s still about 1,200 shy of typical for a title like “Godzilla vs. Kong.”
Recently, ticket sales, while still far below their usual levels, are ticking upward. The best debut of 2021 was “Tom & Jerry,” with $13.7 million in late February. The pandemic-high belongs to “Wonder Woman 1984,” which launched with $16.7 million in December. Each were Warner Bros. releases that landed simultaneously on HBO Max — a once controversial release plan that has helped theaters stay afloat and proved an interesting test case for how viewers prefer to see, and pay for, a movie.
Nevertheless, the Walt Disney Co. recently delayed the planned summer-kickoff of “Black Widow” to July, while pushing a number of titles to its streaming platform, Disney+. Part of what’s holding blockbusters back is the need for a global release to make back their sizable production budgets and marketing spend. (“Godzilla vs. Kong” cost about $160 million to make.) While moviegoing in much of Asia is rejuvenated, rising cases in Europe and in countries like Brazil have, for now, made a full worldwide rollout impossible.
